Cencora price target raised to $227 from $223 at Baird

Baird analyst David Rodgers raised the firm’s price target on Cencora to $227 from $223 and keeps an Outperform rating on the shares. The firm said they reported 3Q results well above expectations, largely driven by DecisionDx-SCC Medicare revenue not included in guidance.